Study Stopped
The current protocol did not satisfy IRB requirements
Comparison of AmnioFix Laser and Standard of Care Treatment
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This is a comparison trial with novel application of AmnioFix and a control arm. Patients electively being treated with facial lasers will be assigned to receive AmnioFix in addition to the normal standard of care placed on half of their face after laser procedure, and normal post laser standard of care alone on the other half of their face. The investigators will investigate the end points of healing, recovery time, re-epitheliaziation, and other cosmetic factors. The study is designed to compare AmnioFix to the current standard of laser care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2016
CompletedFirst Posted
Study publicly available on registry
January 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedMarch 21, 2022
March 1, 2022
January 11, 2016
March 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time of reepithelialization
Subjects' healing and recovery is the primary outcome measure. Reepithelialization will be assessed at each follow up visit, considering the following: erythema, edema/induration, and oozing/drainage.
28 days after treatment
Study Arms (1)
Standard of Care plus AmnioFix
OTHERAll patients will receive the standard of care alone on half of their face, and AmnioFix in addition to the standard of care on the other half of their face.
Interventions
Patients will receive the standard of care alone on half of their face, and AmnioFix in addition to the standard of care on the other half of their face. The standard of care after ablative resurfacing is conservative wound care which may include flexible wound care dressings and/or emollients.
Patients will receive the standard of care dressing only, on their face. The standard of care after ablative resurfacing is conservative wound care which may include flexible wound care dressings and/or emollients.
Eligibility Criteria
You may qualify if:
- adult patients ages 18-100 seeking laser facial treatment
You may not qualify if:
- patients with treatment areas with active or latent infection
- patient with a disorder that would create an unacceptable risk of post-operative complications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCSF Dermatology
San Francisco, California, 94115, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2016
First Posted
January 20, 2016
Primary Completion
April 1, 2017
Study Completion
January 1, 2018
Last Updated
March 21, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share